Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line commercial communications to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.
Otilonium bromide, a drug used in the treatment of irritable bowel syndrome, maintains its efficacy up to 10 weeks following administration. The results of the international study OBIS (Otilonium Bromide in Irritable Bow...
Mimosa Project in collaboration with ANT against ovarian cancer http://www.mimosa-study.com
Ipsen and Menarini announced today the signature of an agreement under which Ipsen, an innovation-driven international specialty pharmaceutical group, grants Menarini exclusive rights for 41 countries for Adenuric® (febuxosta...

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »